The 2014 OTC Guide supplement issue, website, and mobile app, touted on the TODAY show, announce the most recommended OTC products in more than 150 categories.
Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.
To add free press releases please click here.
Astellas today announced progress on the Company's efforts to reshape its research framework at its R&D meeting held in Tokyo on July 10. The meeting provided an opportunity for Astellas to present a comprehensive overview of its late-stage clinical programs and corporate strategy. The purpose of the meeting was to provide an update on the initiatives for Astellas innovation, drug discovery research and pipeline progress.
Strativa Pharmaceuticals Announces FDA Approval of Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device
One Spray per Device, Without the Need for Priming, Provides Greater Ease of Use
Obese patients who underwent surgery or took medications to lose weight were more satisfied with their results than those who made lifestyle changes.
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment
Japanese HCV patients in urgent need of care now have opportunity for cure, including older patients and those with compensated cirrhosis
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time for industry scientists
Par Pharmaceutical Companies, Inc. today issued the following statement in response to inquiries it has received regarding the potential use of Brevital® Sodium (methohexital sodium for injection, USP) by the State of Indiana Department of Correction as part of a three-drug lethal injection protocol:
Cancer immunotherapy research departments need to break their obsession with the latest flavour of the month - checkpoint inhibitors - and concentrate more on combining checkpoint inhibitors with APC activators, thinks Dr. Frederic Triebel, the founder of the French biotech Immutep and an expert in immuno-oncology.
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for injection to Germany
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with current European Pharmacopeia standards
Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients with impetigo
Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial in adult and paediatric patients with impetigo, is available from Ferrer for licensing and commercialisation
Page 1 of 63